GNPX
Genprex, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.45
−0.29%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$6.2K
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$9.40
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +62.3%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | — | -$9.40 | — | — |
| May 13, 2026 | — | -$0.64 | — | — |
| Mar 27, 2026 | -$13 | $9.10 | Beat 170.00% | — |
| Nov 14, 2025 | -$13 | -$5.00 | Beat 60.00% | — |
| Aug 14, 2025 | -$21 | -$8.50 | Beat 59.52% | — |
| Apr 7, 2025 | -$0.82 | -$1.15 | Miss -40.24% | $9.9K |
| Aug 9, 2024 | -$2.30 | -$3.00 | Miss -30.43% | — |
| May 15, 2024 | -$2.54 | -$3.69 | Miss -45.28% | — |
| Mar 29, 2024 | -$3.93 | -$3.96 | Miss -0.76% | $23.2K |
| Nov 14, 2023 | -$0.11 | -$5.20 | Miss -4627.27% | — |
| Aug 21, 2023 | -$4.80 | -$6.00 | Miss -25.00% | — |
| May 22, 2023 | -$4.80 | -$7.60 | Miss -58.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026